Omeros (OMER) Gross Profit (2014 - 2026)

Omeros' (OMER) quarterly Gross Profit came in at $9.3 million in Q1 2026, down 68.64% quarter-over-quarter from $29.7 million in Q3 2021.

Omeros (OMER) Gross Profit (2014 - 2026) Analysis & Trends

Omeros has disclosed Gross Profit across 9 years of filings, most recently posting $9.3 million for Q1 2026.

Gross Profit for Q1 2026 came in at $9.3 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $67.5 million (down 14.56% YoY), and the FY2021 annual result was $80.1 million, up 9.87% from the prior year.
Gross Profit came in at $9.3 million for Q1 2026 at Omeros, down from $29.7 million in the prior quarter.
In the past five years, Gross Profit ranged from a high of $9.3 million in Q1 2026 to a low of $9.3 million in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Omeros	737.87 Mn	602.55 Mn	9.31 Mn

Download Data